Successful Treatment of Transplanted Kidney Patient with 100% Lung Damage Caused by COVID-19 Bilateral Pneumonia: a Clinical Case

QR Code

Successful Treatment of Transplanted Kidney Patient with 100% Lung Damage Caused by COVID-19 Bilateral Pneumonia: a Clinical Case

Background. The new SARS-CoV-2 coronavirus infection is understudied; despite its worldwide prevalence, case reports of organ transplant recipients are rare.Aim. A dynamics evaluation and treatment outcome improvement in a transplanted cadaveric kidney patient with 100% parenchymal lung damage cause...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. R. Nuriakhmetov, V. S. Panteleev, A. R. Zagitov, M. A. Nartailakov, M. N. Kornilov, I. I. Biganyakov
Format:	Article
Language:	English
Published:	Bashkir State Medical University 2022-06-01
Series:	Креативная хирургия и онкология
Subjects:	kidney transplantation allotransplantation covid-19 coronavirus infection sars-cov-2 viral pneumonia immunosuppression
Online Access:	https://www.surgonco.ru/jour/article/view/676
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case report: thermal helium in the treatment of coronavirus pneumonia caused by new coronavirus infection COVID-19 (SARS-CoV-2)
by: S. V. Zhuravel’, et al.
Published: (2021-04-01)

Development crisis of rejection transplant on a background of leucopenia
by: A. A. Korzenewsky, et al.
Published: (2016-02-01)

USE OF TACROLIMUS IN CHILDREN FOR TRANSPLANTATION OF KIDNEYS TAKEN FROM LIVE RELATIVE DONORS
by: V. A. Goryainov, et al.
Published: (2014-05-01)

COVID-19 infection after recent heart transplantation: a case report
by: V. I. Vechorko, et al.
Published: (2020-06-01)

A novel coronavirus infection COVID-19 in practice of obstetrician-gynecologist: a review of current data and guidelines
by: E. Yu. Iupatov, et al.
Published: (2020-07-01)

Simultaneous laparoscopic bilateral nephroureterectomy, cadaveric kidney allotransplantation and performance of vesicostomy in a patient with neurogenic bladder
by: S. V. Arzumanov, et al.
Published: (2020-04-01)

Low-Dose Radiotherapy for Severe COVID-19 Lung Disease—Have Meta-Analyses Accounted for Dose and Timing of Radiotherapy?
by: Leonie Eastlake, et al.
Published: (2025-06-01)

Coronavirus Replication: Genomes, Subgenomic RNAs, and Defective Viral Genomes
by: Rory Williams, et al.
Published: (2025-05-01)

Clinical course and approaches to therapy in kidney transplant recipients with the novel COVID-19 disease
by: O. N. Kotenko, et al.
Published: (2021-01-01)

Results of Detecting SARS-CoV-2 and Other Pathogens of Community-Acquired Pneumonia by PCR in the Tyumen Region
by: I. V. Bakshtanovskaya, et al.
Published: (2020-10-01)

Gastrointestinal Tract Disorders in COVID-19 Infected Children
by: R. V. Popova, et al.
Published: (2020-10-01)

Coronavirus disease COVID-2019
by: B. K. Romanov
Published: (2020-03-01)

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
by: Sofia M. Gulova, et al.
Published: (2025-07-01)

Cognitive dysfunctions in patients after coronavirus pneumonia with respiratory insufficiency
by: A. O. Mikhailov, et al.
Published: (2023-06-01)

Experimental Swine Models for Vascularized Composite Allotransplantation and Immunosuppression: A Systematic Review and Case Report of a Novel Heterotopic Hemifacial Swine Model
by: Leonard Knoedler, et al.
Published: (2025-07-01)

Community-aquired pneumonia associated with coronavirus disease (COVID-19): determination of pathological process progression predictors by clinical and hemocoagulation parameters
by: T.O. Pertseva, et al.
Published: (2022-03-01)

Eye damage in COVID-19. Part 1: Involvement of the eye in SARS-CoV-2 virus transmission and anterior segment complications
by: N. I. Kurysheva, et al.
Published: (2022-12-01)

Prediction of Mortality in ICU Patients with SARS-CoV-2-Associated Pneumonia
by: P. N. Savilov, et al.
Published: (2025-04-01)

Possibilities of suppressing the cytopathogenic effect of SARS-CoV-2 coronavirus according to the results of the antiviral activity of Cytovir®-3 <i>in vitro</i> study
by: V. S. Smirnov, et al.
Published: (2021-08-01)

Clinical and laboratory features of COVID-19 in young people
by: A. Kh. Nurpeisova, et al.
Published: (2021-07-01)

Modern vaccines and coronavirus infections
by: Yu. A. Belikova, et al.
Published: (2020-12-01)

An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare
by: D. V. Gorenkov, et al.
Published: (2020-03-01)

Radiology of viral pneumonia
by: A. A. Speranskaia, et al.
Published: (2016-07-01)

Early Changes in Clinical and Laboratory Parameters in Patients Died of COVID-19
by: K. S. Bakhtiyarova, et al.
Published: (2022-10-01)

ALLOTRANSPLANTATION OF MACROENCAPSULATED PARATHYROID CELLS IN SEVERE POSTSURGICAL HYPOPARATHYROIDISM: A CASE REPORT
by: V. Ja. Khryshchanovich, et al.
Published: (2011-12-01)

Disinfection of Surfaces Contaminated with SARS-CoV-2 Coronavirus by UV Radiation of Low-Pressure Mercury-Vapour Lamp
by: D. N. Masyakin, et al.
Published: (2023-07-01)

Infectious comorbidities in patients with rheumatoid arthritis: Status praesens
by: B. S. Belov, et al.
Published: (2019-09-01)

SARS-CoV-2 and Streptococcus pneumoniae colonization and disease: an observational study in adults
by: Sara Calvo-Silveria, et al.
Published: (2025-07-01)

Pancreatic islets as a SARS-CoV-2 target
by: O. V. Vorobеva
Published: (2023-01-01)

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
by: Hailong Guo, et al.
Published: (2023-12-01)

Is anticoagulant therapy necessary after hospitalization with COVID-19 pneumonia?
by: P. A. Davtyan, et al.
Published: (2022-02-01)

Issues of COVID-19 morphological diagnosis in the practice of forensic medicine
by: S. A. Stepanov, et al.
Published: (2022-07-01)

COVID-19 therapy: from myths to reality and hopes
by: S. V. Bozrova, et al.
Published: (2020-12-01)

Disease course, obstetric and perinatal outcomes in pregnant women with COVID-19 (literature review)
by: M. D. Sanaeva, et al.
Published: (2022-07-01)

Effect of vaccination on morbidity and mortality from community-acquired pneumonia
by: T. A. Bayanova, et al.
Published: (2024-03-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

Russian vaccines against COVID-19: their characteristics, efficacy and safety
by: A. E. Bilev, et al.
Published: (2023-01-01)

Severe diseases of the anterior segment of the eye accompanied by somatic pathology and COVID-19: clinical cases under the pandemic
by: O. I. Lebedev, et al.
Published: (2022-06-01)

COVID-19 Pneumonia Pneumomediastinum. Clinical Cases
by: N. А. Lesteva, et al.
Published: (2021-07-01)

Antigenic properties of sARs-CoV-2/human/RUs/nsk-FRCFtM-1/2020 coronavirus isolate from a patient in novosibirsk
by: A. A. Chepurnov, et al.
Published: (2020-08-01)